Epigenetics Market (Covid-19) Impact and Analysis by 2025 | By Merck KGaA, Thermo Fisher Scientific, ABCAM, Agilent Technologies, Active Motif, Qiagen, Bio-Rad Laboratories, Perkinelmer, New England Biolabs (NEB), and Illumina

The Insight Partners analysts forecasts the latest report on “Epigenetics Market (Covid-19) Impact and Analysis by 2025”, according to report; The Epigenetics Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Epigenetics Market.

The study provides details such as the market share, Market Insights, Strategic Insights, Segmentation and key players in the Epigenetics Market.

Download Sample Report of Epigenetics Market Report @ https://www.theinsightpartners.com/sample/TIPHE100000971/?openpr-10225

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

The epigenetics market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 18.5% from 2018-2025.

Some of the Major Market Players Are:

Merck KGaA
Thermo Fisher Scientific Inc.
ABCAM Plc
Agilent Technologies
Active Motif
Qiagen
Bio-Rad Laboratories, Inc.
Perkinelmer Inc.
New England Biolabs (NEB)
Illumina Inc.

Market Insights

Declining Prices of Sequencing
The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. The costs associated with DNA sequencing performed at the sequencing centers, which is funded by the Institutes, has tracked by the National Human Genome Research Institute (NHGRI) for many years. This information has served as a key standard for establishing the DNA sequencing capacity and considering improvements in DNA sequencing technologies of the NHGRI Genome Sequencing Program (GSP). In the recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduce to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, that upsurge the growth of the market

Product-Based Insights

In 2017, the kits segment held a largest market share in the epigenetics market, by product. This segment is also expected to dominate the market in 2025 owing to availability of several kits in the market for the gene expression analysis such as MicroRNA analysis, SNP genotyping analysis and other procedures. Furthermore, the reagents segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

Technology-Based Insights

In 2017, the DNA methylation segment held a largest market share in the epigenetics market, by technology. This segment is also expected to dominate the market in 2025 as the technology mechanistic change in genomic conformation sets out a platform for various cellular processes, such as the exposure of the promoter of a specific gene to its transcriptional machinery. Chromatin remodelling, DNA methylation and histone posttranslational modifications (PTMs), which are known as important long-term memory processes. Furthermore, the technology segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

Application-Based Insights

Oncology segment is anticipated to grow at the highest CAGR during the forecast period. The epigenetics offers prodigious potential for the identification of biomarkers that can be used to detect and diagnose cancer in its earliest stages. Therefore, the segment held the largest share by application in the epigenetics market and is likely to retain its dominance during the forecast period.

End User-Based Insights

In 2017, the pharmaceuticals & biotechnological companies segment held a largest market share in the epigenetics market, by end user. This segment is also expected to dominate the market in 2025. However, the contract research organizations segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

Strategic Insights

Product launches and merger and acquisitionsare the commonly adopted strategies by companies to expand their global footprintsand product portfolios, which helpthem,meet the growing consumer demand. Product launches areamong the major strategies adopted by the epigeneticsmarketplayers to enlarge their respective customer bases; this also permits them maintain their brand name globally.

Epigenetics Market– By Product

Reagents
Kits
Enzymes
Instruments & Consumables
Bioinformatics Tools

Epigenetics Market – By Technology

Histone Modification
DNA Methylation
Others

Epigenetics Market– By Application

Metabolic Diseases
Oncology
Cardiovascular Diseases
Others

Epigenetics Market– By End User

Academics & Research Institutes
Contract Research Organizations
Biotechnology & Pharmaceutical Companies

The report analyses factors affecting the Epigenetics Market from further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Epigenetics Market in these regions.

Moreover, the report entails the estimate and analysis for the Epigenetics Market on a global as well as regional level. The study provides historical data as well as the trending features and future predictions of the market growth. Further, the report encompasses drivers and restraints for the Epigenetics Market growth along with its impact on the overall market development. In addition, the report provides an analysis of the accessible avenues in the market on a global level.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Epigenetics Market based on various segments. It also provides market size and forecast estimates from the year 2018 to 2027 with respect to five major regions. The Epigenetics Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Promising Regions & Countries Mentioned in The Epigenetics Market Report:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East & Africa

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Major Features of Epigenetics Market Report:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Epigenetics market
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Epigenetics market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Purchase a copy of Epigenetics Market research report @ https://www.theinsightpartners.com/buy/TIPHE100000971/?openpr-10225

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.